Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEMENTO
2022-502316-36-00Phase 4Completed
- Sponsor
- MyoKardia
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 17
01
Overview
Phase 4, randomised, double-blind trial in Hypertrophic Obstructive Cardiomyopathy (HOCM) comparing Mavacamten with Placebo (2 arms). Started Feb 2024; status: completed.
02
Drugs
mavacamten
03
Conditions
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Beyond the preview
Go deeper on 2022-502316-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502316-36-00.